HomeNewsBusinessCOVID-19 impact: HCL Tech’s recruitment process in India to go virtual

COVID-19 impact: HCL Tech’s recruitment process in India to go virtual

The company will recruit 15,000 freshers and honour all the offers.

May 27, 2020 / 12:32 IST
Story continues below Advertisement

HCL Technologies’ recruitment process will be virtual this year in the wake of COVID-19 and this is likely to stay, said VV Apparao, Chief Human Resources Officer of the company.

In a recent interaction with Moneycontrol, Apparao said, “We will remain 100 percent virtual in on-boarding and recruitment,” and added that it gives the company a lot of flexibility.

Story continues below Advertisement

“Today, we don’t have to meet any candidate and our on-boarding is online too. As we speak, we are trying to recruit 4,000-odd people and we are not calling anyone to office. Interview panels are virtual, candidates come online, offers go online and they are on-boarded online,” he added.

Earlier, candidates and panelists will find time to meet, at times travelling long distances. Then panelists have to sit together and collate the information and take a decision. “The whole process takes a long time and requires a huge amount of coordination. Now our process is completely digital,” Apparao noted.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show